FutureGen Biopharmaceutical
Nanjing, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A Chinese biotech developing innovative antibody-based therapies for cancer and autoimmune diseases.
ImmunologyOncology
Technology Platform
Proprietary antibody discovery and protein engineering platform for generating optimized monoclonal and bispecific antibodies.
Opportunities
Large and growing domestic demand for innovative cancer and autoimmune therapies presents a significant market opportunity.
Risk Factors
High clinical development risk and intense competition could challenge differentiation and commercial success.
Competitive Landscape
Competes in the crowded Chinese antibody therapeutics space against companies like Innovent Biologics and Hengrui Medicine.